Different transcriptional expression of KIAA1324 and its splicing variants in human carcinoma cell lines with different metastatic capacity

Oncology Reports

Volumn 11, Issue 3, 2004, Pages 677-680

  Bauer, Mario ^a   Aust, Gabi ^a   Schumacher, Udo ^b  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b UNIVERSITY OF HAMBURG   (Germany)

Author keywords

Alternative splicing; Epithelial carcinoma cell line; KIAA1324

Indexed keywords

COMPLEMENTARY DNA; KIAA1324 PROTEIN, HUMAN; MESSENGER RNA; ONCOPROTEIN; RNA; TUMOR PROTEIN;

AGAR GEL ELECTROPHORESIS; ALTERNATIVE RNA SPLICING; ARTICLE; BIOSYNTHESIS; CARCINOMA; CHEMISTRY; EXON; GENETIC TRANSCRIPTION; HUMAN; METABOLISM; METASTASIS; MOLECULAR CLONING; NUCLEIC ACID HYBRIDIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE;

ALTERNATIVE SPLICING; CARCINOMA; CELL LINE, TUMOR; CLONING, MOLECULAR; DNA, COMPLEMENTARY; ELECTROPHORESIS, AGAR GEL; EXONS; HUMANS; NEOPLASM METASTASIS; NEOPLASM PROTEINS; NUCLEIC ACID HYBRIDIZATION; ONCOGENE PROTEINS, FUSION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; RNA, MESSENGER; TRANSCRIPTION, GENETIC;

EID: 4644311998     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.11.3.677     Document Type: Article

References (24)

1. Kakiuchi S, Daigo Y, Tsunoda T, Yano S, Sone S and Nakamura Y: Genome-wide analysis of organ-preferential metastasis of human small cell lung cancer in mice. Mol Cancer Res 1: 485-499, 2003. (Pubitemid 36577045)
2. Okabe H, Satoh S, Kato T, Kitahara O, Yanagawa R, Yamaoka Y, Tsunoda T, Furukawa, Y and Nakamura Y: Genome-wide analysis of gene expression in human hepatocellular carcinomas using cDNA microarray: identification of genes involved in viral carcinogenesis and tumor progression. Cancer Res 61: 2129-2137, 2001. (Pubitemid 32692038)
3. Kitahara O, Furukawa Y, Tanaka T, Kihara C, Ono K, Yanagawa R, Nita ME, Takagi T, Nakamura Y and Tsunoda T: Alterations of gene expression during colorectal carcinogenesis revealed by cDNA microarrays after laser-capture microdissection of tumor tissues and normal epithelia. Cancer Res 61: 3544-3549, 2001. (Pubitemid 32694957)
4. Golub TR, Slonim DK, Tamayo P, Huard C, Gaasenbeek M, Mesirov JP, Coller H, Loh ML, Downing JR, Caligiuri MA, Bloomfield CD and Lander ES: Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 286: 531-537, 1999.
5. Chakrabarti R, Robles LD, Gibson J and Muroski M: Profiling of differential expression of messenger RNA in normal, benign and metastatic prostate cell lines. Cancer Genet Cytogenet 139: 115-125, 2002. (Pubitemid 36110652)
6. Ramaswamy S, Ross KN, Lander ES and Golub TR: A molecular signature of metastasis in primary solid tumors. Nat Genet 33: 49-54, 2003. (Pubitemid 36068681)
7. Forozan F, Mahlamäki EH, Monni O, Chen Y, Veldman R, Jiang Y, Gooden GC, Ethier SP, Kallioniemi A and Kallioniemi OP: Comparative genomic hybridization analysis of 38 breast-cancer cell lines: a basis for interpreting complementary DNA microarray data. Cancer Res 60: 4519-4525, 2000. (Pubitemid 32103634)
8. Hampton R, Walker M, Marshall J and Juhl H: Differential expression of carcinoembryonic antigen (CEA) splice variants in whole blood of colon cancer patients and healthy volunteers: implication for the detection of circulating colon cancer cells. Oncogene 7: 7817-7823, 2002. (Pubitemid 35398839)
9. Schumacher U and Adam E: Lectin histochemical HPA-binding pattern of human breast and colon cancers is associated with metastases formation in severe combined immunodeficient mice. Histochem J 29: 677-684, 1997. (Pubitemid 27489870)
10. Aust G, Heuer M, Laue S, Lehmann I, Hofmann A, Heldin NE and Scherbaum WA: Expression of tumour necrosis factor-alpha (TNF-alpha) mRNA and protein in pathological thyroid tissue and carcinoma cell lines. Clin Exp Immunol 105: 148-154, 1996. (Pubitemid 26231838)
11. Zellmer S and Reisig D: Isolation cultivation and differentiation of normal human epidermal keratinocates in serum-free medium. In: Epithelial Cell Culture. Wise C (ed). Humana Press, Totowa, NJ, 2001.
12. Sattler M and Salgia R: Molecular and cellular biology of small cell lung cancer. Semin Oncol 30: 57-71, 2003. (Pubitemid 36254675)
13. De Marzo AM, Nelson WG, Isaacs WB and Epstein JI: Pathological and molecular aspects of prostate cancer. Lancet 361: 955-964, 2003. (Pubitemid 36332115)
14. Qin LX: Chromosomal aberration related to metastasis of human solid tumors. World J Gastroenterol 15: 769-776, 2002.
15. Recio JA and Merlino G: Hepatocyte growth factor/scatter factor induces feedback up-regulation of CD44v6 in melanoma cells through Egr-1. Cancer Res 63: 1576-1582, 2003. (Pubitemid 36373646)
16. Caballero OL, De Souza S J, Brentani RR and Simpson AJ: Alternative spliced transcripts as cancer markers. Dis Markers 17: 67-75, 2001. (Pubitemid 32964838)
17. Modrek B and Lee C: A genomic view of alternative splicing. Nat Genet 30: 13-19, 2002.
18. Xu Q, Modrek B and Lee C: Genome-wide detection of tissue-specific alternative splicing in the human transcriptome. Nucleic Acids Res 17: 3754-3766, 2002. (Pubitemid 35012448)
19. Bartel F, Taubert H and Harris LC: Alternative and aberrant splicing of MDM2 mRNA in human cancer. Cancer Cell 2: 9-15, 2002. (Pubitemid 41043984)
20. Line A, Slucka Z, Stengrevics A, Li G and Rees RC: Altered splicing pattern of TACC1 mRNA in gastric cancer. Cancer Genet Cytogenet 139: 78-83, 2002. (Pubitemid 36120415)
21. Matsumoto R, Tada M, Nozaki M, Zhang CL, Sawamura Y and Abe H: Short alternative splice transcripts of the mdm2 oncogene correlate to malignancy in human astrocytic neoplasm Cancer Res 58: 609-613, 1998. (Pubitemid 28099465)
22. Evans SC, Vismanathan M, Grier JD, Narajana M, El-Naggar AK and Lozano G: An alternatively spliced HDM2 product increases p53 activity by inhibiting HDM2. Oncogene 20: 4041-4049, 2001. (Pubitemid 32681609)
23. Lukas J, Gao DQ, Keshmeshian M, Wen WH, Tsao-Wei D, Rosenberg S and Press MF: Alternative and aberrant messenger RNA splicing of the mdm2 oncogene in invasive breast cancer. Cancer Res 61: 3212-3219, 2001. (Pubitemid 32691978)
24. Friedrichs K, Franke F, Lisboa BW, Kugler G, Gille I, Terpe HJ, Holzel F, Maass H and Gunthert U: CD44 isoforms correlate with cellular differentiation but not with prognosis in human breast cancer. Cancer Res 55: 5424-5433, 1995.